Implications of IDH mutations on immunotherapeutic strategies for malignant glioma.
Sign Up to like & getrecommendations! Published in 2022 at "Neurosurgical focus"
DOI: 10.3171/2021.11.focus21604
Abstract: Immunotherapy has emerged as a promising approach for treating aggressive solid tumors, even within the CNS. Mutation in the metabolic gene isocitrate dehydrogenase 1 (IDH1) represents not only a major glioma defining biomarker but also… read more here.
Keywords: implications idh; mutations immunotherapeutic; malignant glioma; idh mutations ... See more keywords